Skip to main content
. 2022 Oct 7;12:966920. doi: 10.3389/fonc.2022.966920

Figure 6.

Figure 6

Independent prognostic role of the cuproptosis-related lncRNA signature for AML patients. (A, B) Univariate and multivariate Cox regression analysis of clinical factors including sex, French-American-British (FAB) subtype, age, blasts in bone marrow (BM), white blood counts (WBC), and molecular risk stratification and risk score for OS. (C) Nomogram that integrated the risk score and clinical factors predicts the probability of the 1-, 3-, and 5-year OS. (D) The calibration curves for 1-, 3-, and 5-year OS.